
Bridging Trials Closer to Patients
A review of survey results looking at bridging clinical research and clinical health care.
Next week, I will be presenting at the
As I noted in that September article, “The inherent flaw with this survey, of course, is that it was only distributed to a clinical trials audience. Therefore, there would be a bias toward the interests and ideas related to this industry vs. healthcare.” With the help of our sister publications that cover business and therapeutic-specific areas for practicing physicians, we deployed a survey around their views on clinical research.
While the surveys were not one-to-one, meaning not all of the questions and answers were listed in the same way or contained the same choices, they did offer some compelling views.
Here are some one-to-ones for the clinical research (CR) and clinical care (CC) respondents:
- 43% CR have an initiative to increase collaboration between healthcare and research; while 19% of CC do.
- 35.5% of CR vs. 57% of CC believe the primary benefit to increasing collaboration between clinical research and healthcare is greater access to clinical trials/research as a care option
- 60% of CC believe the Physician practices/networks are least likely to work on integrating clinical research and healthcare vs. 21% of CR.
But even with the challenges, I was encouraged by the profile of the healthcare respondents and responses that were positive around the potential for integration. That clinical care audience reflected the following:
- 63% were physicians
- 94% interact with patients on a daily basis
- 93% are familiar with clinical trials and how they are conducted
- 85% would use their EHR/EMRs to flag potential clinical trial for their patient, if it had that capability
- 31% of respondents already have a physician referral system in place to offer potential patients into trials
And best of all was that 74% of respondents would be interested to learn more about clinical research as a care option.
I’m looking forward to the conversation at the conference, as well as keeping the dialogue going through our website and pages.
Lisa Henderson is Editor-in-Chief of Applied Clinical Trials. She can be reached at




